A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TBConor Tweed, Stephen H. Gillespie, Evans Amukoye et al.|The International Journal of Tuberculosis and Lung Disease|2021Cited by 63
Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trialRay Y. Chen, Laura E. Via, Lori E. Dodd et al.|Gates Open Research|2017Cited by 45